← Leaderboards
Sandro Santagata
Brigham And Women'S Hospital
$8,660,973
Attributed
$10,287,136
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.1M · FY2008–25$20M$15M$10M$5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,937,904 · 8
By mechanism
U2C$11,703,027 · 2
R01$3,852,203 · 2
U01$1,418,097 · 1
K08$899,827 · 1
S10$600,000 · 1
R21$464,750 · 1
Top collaborators
- Hanspeter Pfister4 shared
- Peter Karl Sorger3 shared
- Peter Tsvetkov3 shared
- Jon C Aster1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Robert O Wright$90,369,790
- Bradley Maron$8,442,424
- Matthew Gombolay$1,716,878
- Roger Daglius Dias$1,716,878
- Bharti Khurana$2,608,420
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMalignant NeoplasmsTumorCollaborationsProteinsTissuesSpecimenProgramsMutationMolecularBiologicalComplexBaseStructureGeneticDesignImageReagentAtlasesMemberTissue ImagingTechnologyTrainingCell Proliferation
Grant awards (24)
Mechanisms Promoting Copper Dependent Cell Death in Cancer$595,634
R01 · FY2025 · CA
Revolutionizing Renal Histopathology: Integrating Multiplexed Immunofluorescence and ML/AI Image-Based Biomarkers for Precision Diagnosis and Patient Stratification$464,750
R21 · FY2025 · DK · contact PI
Visual Analytics for Exploration and Hypothesis Generation Using Highly MultiplexedSpatial Data of Tissues and Tumors$416,968
U01 · FY2025 · CA
Mechanisms Promoting Copper Dependent Cell Death in Cancer$648,408
R01 · FY2024 · CA
Orion: A novel platform for rapid multiplexed tissue imaging$600,000
S10 · FY2024 · OD · contact PI
Visual Analytics for Exploration and Hypothesis Generation Using Highly MultiplexedSpatial Data of Tissues and Tumors$500,943
U01 · FY2024 · CA
IMAT-ITCR Collaboration: Multiplexed Spatial Data calibration and analysis using micro-capsules$84,750
U01 · FY2024 · CA
Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center)$757,397
U2C · FY2023 · CA
Mechanisms promoting copper dependent cell death in cancer$590,188
R01 · FY2023 · CA
Visual Analytics for Exploration and Hypothesis Generation Using Highly MultiplexedSpatial Data of Tissues and Tumors$415,436
U01 · FY2023 · CA
Molecular, Cellular, and Tissue Characterization Unit$254,428
U2C · FY2023 · CA · contact PI
Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center)$974,841
U2C · FY2020 · CA
Investigating the HSF1 Cancer Network$406,031
R01 · FY2020 · CA · contact PI
Investigating the HSF1 Cancer Network$393,849
R01 · FY2019 · CA · contact PI
Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center)$6,918,530
U2C · FY2018 · CA
Molecular, Cellular, and Tissue Characterization Unit$2,797,831
U2C · FY2018 · CA · contact PI
Investigating the HSF1 Cancer Network$406,031
R01 · FY2018 · CA · contact PI
Investigating the HSF1 Cancer Network$406,031
R01 · FY2017 · CA · contact PI
Investigating the HSF1 Cancer Network$406,031
R01 · FY2016 · CA · contact PI
Heat Shock Directed Drug Discovery For The Treatment Of Gliomas$188,107
K08 · FY2012 · NS · contact PI
Heat Shock Directed Drug Discovery For The Treatment Of Gliomas$177,930
K08 · FY2011 · NS · contact PI
Heat Shock Directed Drug Discovery For The Treatment Of Gliomas$177,930
K08 · FY2010 · NS · contact PI
Heat Shock Directed Drug Discovery For The Treatment Of Gliomas$177,930
K08 · FY2009 · NS · contact PI
Heat Shock Directed Drug Discovery For The Treatment Of Gliomas$177,930
K08 · FY2008 · NS · contact PI